Omisirge: A Groundbreaking Advancement in Cord Blood Stem Cell Treatment
Important Note: Americord is not affiliated with Gamida Cell or the Omisirge product. At this [...]
Breaking News: First Person to be Cured of HIV Using Cord Blood Stem Cells
February 16, 2022 - A woman of mixed race is the first to be cured [...]
Americord Registry® Celebrates Opening of In-House Stem Cell Processing and Research & Development Lab
Americord Registry®, a leading provider of umbilical cord blood, cord tissue, and placental tissue banking, [...]
Americord Welcomes Casey Stoneman Roberson as Director of Marketing & Brand Development
Americord Registry, a leading provider of stem cell and cord blood storage, today announced [...]
Americord Distributes Thousands of Face Masks to Impacted OBGYN Practices
During the height of the pandemic, specifically in May of 2020, we at Americord [...]
Cord Blood Banking Cost Comparison: CBR, Viacord and Americord
Americord is the best quality cord blood bank. We are competitively priced towards our major [...]
Harvard Researchers Expand Cord Blood Stem Cells | Americord
In phase 1 of a clinical trial at the Harvard Stem Cell Institute (HSCI), Harvard [...]
What’s Your Cord Blood Banking Knowledge? | Americord
49% of expectant parents are aware but, minimally informed about cord blood banking. How much [...]
Americord Yields 60% More CD34+ Stem Cells
Americord Yields 60% More CD34+ Stem Cells, 54% More Cord Blood, and 34% Higher TNC [...]
All About Cord Blood Banking: Wednesday Wisdom | Americord
This original article was posted on Baby Proofed Parents and written by Kirsten Brunner, MA, LPC. Twelve [...]